University of California San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT01284296
This study will further investigate the Masimo SpHb [FDA Approved] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
San Francisco, California, 94143, United States
We have completed a study with 20 patients using the latest version of the SpHb monitor software and finger sensor.
The purpose of this study is to assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb) following the digital block.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One dose of lidocaine 2% injected locally into one finger (2 mls total)
Masimo SpHb continuous hemoglobin monitor
Time frame: A minimum of 2-4 differences recorded approximately hourly during surgery
University of California, San Francisco
Other
Comparison of Three Methods of Hemoglobin Monitoring in Patients Undergoing Spine or Hip Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07305883
Digital Block, Neurologic Manifestations
View Trial Details